New research uncovers new insights into preventing chronic inflammation caused by aging-related zombie-like cells. In humans ...
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
New research from an international team of plant biologists, led by researchers at the VIB-UGent Center for Plant Systems ...